The Claim
In psoriasis-like human keratinocytes, zinc oxide nanoparticles induce intracellular cleavage of trappin-2/pre-elafin via a non-canonical pathway that is absent in healthy keratinocytes.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Zinc oxide nanoparticles cause a specific molecular change in skin cells from psoriasis-affected tissue that does not occur in healthy skin cells.
See the scientific wording
In psoriasis-like human keratinocytes, zinc oxide nanoparticles trigger intracellular cleavage of trappin-2/pre-elafin through a non-canonical pathway not observed in healthy keratinocytes, indicating a disease-specific molecular response to nanoparticle exposure.
In skin cells from psoriasis-affected tissue, zinc oxide nanoparticles enter the cells and release zinc ions that create a highly reactive environment. This environment, combined with existing changes in the diseased cells, activates a unique enzyme pathway that cuts apart a protective skin protein called trappin-2/pre-elafin in a way that does not happen in healthy skin cells. The broken pieces of this protein lose their normal protective function and may worsen inflammation and tissue damage.
What the research says
1 studyIn skin cells from people with psoriasis, zinc oxide nanoparticles caused a special change in a skin protein that doesn't happen in normal skin cells — meaning the disease changes how the skin reacts to these particles.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.